Article
The Clinical Significance of PPAR Gamma Agonism.
Current molecular medicine - 1 May 2005
Campbell I W
Abstract excerpt
Insulin resistance is a principal underlying defect in type 2 DM along with beta-cell dysfunction, and this insulin resistance underpins many of the abnormalities associated with the metabolic syndrome. Peroxisome-proliferator-activated receptor gamma agonists (PPARgamma agonists), also known as glitazones or thiazolidinediones (TZDs) are powerful insulin sensitisers with recent evidence suggesting that they also...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
